CAVACURMIN®: Study Reveals Increased Metabolic Bioavailability of Tetrahydrocurcumin
Munich, May 6, 2021 – A study recently published in the Journal of Functional Foods shows that ingestion of the curcumin-cyclodextrin complex CAVACURMIN® leads to an increased metabolic bioavailability of tetrahydrocurcumin. A large portion of supplemented curcumin is converted into tetrahydrocurcumin in the body. This metabolite is credited with anti-inflammatory and antioxidant properties. CAVACURMIN® is the only formulation on the market that demonstrably boosts the bioavailability of both curcumin and tetrahydrocurcumin.För mer information se bifogad pressrelease